Most treatment options for cervical intraepithelial neoplasia 2/3 (CIN2/3) are either excisional or ablative, and require sequential visits to health care providers. Connie Trimble, M.D.discusses recent advancements in studies performed to assess the safety and efficacy of self-administered artesunate vaginal inserts in biopsy-confirmed cervical intraepithelial neoplasia patients.

Related Presenters

Cornelia Trimble, MD

Professor of Gynecology and Obstetrics

Professor of Gynecology and Obstetrics Expertise: Cervical Cancer, Cervical Dysplasia, Gynecology and Obstetrics, Human Papillomavirus Infections Research Interests: Cervical Cancer; HPV; Cancer Vaccines; tumor immunology, tumor ...

View full profile